(1)
Ingle, S. J.; Tapar, K. K. QSAR and Docking Studies on 1,2-Benzisoxazole Derivatives for Antipsychotic Activity Against Dopamine Receptor (D2). Cur Res Pharm Sci 2016, 6, 31-34.